Ginsenoside Rh2 induces ligand-independent Fas activation via lipid raft disruption
Lipid rafts are plasma membrane platforms mediating signal transduction pathways for cellular proliferation, differentiation and apoptosis. Here, we show that membrane fluidity was increased in HeLa cells following treatment with ginsenoside Rh2 (Rh2), as determined by cell staining with carboxy-lau...
Gespeichert in:
Veröffentlicht in: | Biochemical and biophysical research communications 2009-07, Vol.385 (2), p.154-159 |
---|---|
Hauptverfasser: | , , , , , , |
Format: | Artikel |
Sprache: | eng |
Schlagworte: | |
Online-Zugang: | Volltext |
Tags: |
Tag hinzufügen
Keine Tags, Fügen Sie den ersten Tag hinzu!
|
container_end_page | 159 |
---|---|
container_issue | 2 |
container_start_page | 154 |
container_title | Biochemical and biophysical research communications |
container_volume | 385 |
creator | Yi, Jae-Sung Choo, Hyo-Jung Cho, Bong-Rae Kim, Hwan-Myung Kim, Yong-Nyun Ham, Young-Mi Ko, Young-Gyu |
description | Lipid rafts are plasma membrane platforms mediating signal transduction pathways for cellular proliferation, differentiation and apoptosis. Here, we show that membrane fluidity was increased in HeLa cells following treatment with ginsenoside Rh2 (Rh2), as determined by cell staining with carboxy-laurdan (C-laurdan), a two-photon dye designed for measuring membrane hydrophobicity. In the presence of Rh2, caveolin-1 appeared in non-raft fractions after sucrose gradient ultracentrifugation. In addition, caveolin-1 and GM1, lipid raft landmarkers, were internalized within cells after exposure to Rh2, indicating that Rh2 might disrupt lipid rafts. Since cholesterol overloading, which fortifies lipid rafts, prevented an increase in Rh2-induced membrane fluidity, caveolin-1 internalization and apoptosis, lipid rafts appear to be essential for Rh2-induced apoptosis. Moreover, Rh2-induced Fas oligomerization was abolished following cholesterol overloading, and Rh2-induced apoptosis was inhibited following treatment with siRNA for Fas. This result suggests that Rh2 is a novel lipid raft disruptor leading to Fas oligomerization and apoptosis. |
doi_str_mv | 10.1016/j.bbrc.2009.05.028 |
format | Article |
fullrecord | <record><control><sourceid>proquest_osti_</sourceid><recordid>TN_cdi_osti_scitechconnect_22199742</recordid><sourceformat>XML</sourceformat><sourcesystem>PC</sourcesystem><els_id>S0006291X09009358</els_id><sourcerecordid>67339750</sourcerecordid><originalsourceid>FETCH-LOGICAL-c382t-a1be4078561de86c21380f25330fc8e0b42383305c30183dc7eb72a06830b9003</originalsourceid><addsrcrecordid>eNp9kE1r3DAQhkVoaTab_oEciqGQm52R5A8JcikhXxAI9ANyE7I0brTsyo4kL_TfR2YXestlhmHeeRgeQi4oVBRoe7Wp-j6YigHICpoKmDghKwoSSkah_kRWANCWTNKXU3IW4waA0rqVX8gplXXdCClW5Ne98xH9GJ3F4ucrK5y3s8FYbN1f7W2ZR5wwF5-KOx0LbZLb6-RGX-ydzqnJ2SLoIRXWxTBPy-acfB70NuLXY1-TP3e3v28eyqfn-8ebH0-l4YKlUtMea-hE01KLojWMcgEDaziHwQiEvmZc5KExHKjg1nTYd0xDKzj0EoCvyfcDd4zJqWhcQvNqRu_RJMUYlbLLiDW5PKSmML7NGJPauWhwu9UexzmqtuNcds2CY4egCWOMAQc1BbfT4Z-ioBbhaqMW4WoRrqBRWXg--nakz_0O7f-To-EcuD4EMJvYOwzLo-gNWheWP-3oPuK_Aw4tkDg</addsrcrecordid><sourcetype>Open Access Repository</sourcetype><iscdi>true</iscdi><recordtype>article</recordtype><pqid>67339750</pqid></control><display><type>article</type><title>Ginsenoside Rh2 induces ligand-independent Fas activation via lipid raft disruption</title><source>MEDLINE</source><source>Elsevier ScienceDirect Journals</source><creator>Yi, Jae-Sung ; Choo, Hyo-Jung ; Cho, Bong-Rae ; Kim, Hwan-Myung ; Kim, Yong-Nyun ; Ham, Young-Mi ; Ko, Young-Gyu</creator><creatorcontrib>Yi, Jae-Sung ; Choo, Hyo-Jung ; Cho, Bong-Rae ; Kim, Hwan-Myung ; Kim, Yong-Nyun ; Ham, Young-Mi ; Ko, Young-Gyu</creatorcontrib><description>Lipid rafts are plasma membrane platforms mediating signal transduction pathways for cellular proliferation, differentiation and apoptosis. Here, we show that membrane fluidity was increased in HeLa cells following treatment with ginsenoside Rh2 (Rh2), as determined by cell staining with carboxy-laurdan (C-laurdan), a two-photon dye designed for measuring membrane hydrophobicity. In the presence of Rh2, caveolin-1 appeared in non-raft fractions after sucrose gradient ultracentrifugation. In addition, caveolin-1 and GM1, lipid raft landmarkers, were internalized within cells after exposure to Rh2, indicating that Rh2 might disrupt lipid rafts. Since cholesterol overloading, which fortifies lipid rafts, prevented an increase in Rh2-induced membrane fluidity, caveolin-1 internalization and apoptosis, lipid rafts appear to be essential for Rh2-induced apoptosis. Moreover, Rh2-induced Fas oligomerization was abolished following cholesterol overloading, and Rh2-induced apoptosis was inhibited following treatment with siRNA for Fas. This result suggests that Rh2 is a novel lipid raft disruptor leading to Fas oligomerization and apoptosis.</description><identifier>ISSN: 0006-291X</identifier><identifier>EISSN: 1090-2104</identifier><identifier>DOI: 10.1016/j.bbrc.2009.05.028</identifier><identifier>PMID: 19445898</identifier><language>eng</language><publisher>United States: Elsevier Inc</publisher><subject>60 APPLIED LIFE SCIENCES ; Antineoplastic Agents - pharmacology ; APOPTOSIS ; Caveolin 1 - metabolism ; CELL PROLIFERATION ; CHOLESTEROL ; Cholesterol - metabolism ; Fas activation ; fas Receptor - metabolism ; Ginsenoside Rh2 ; Ginsenosides - pharmacology ; HELA CELLS ; Humans ; LIGANDS ; Lipid rafts ; LIPIDS ; Membrane Microdomains - drug effects ; Membrane Microdomains - metabolism ; PHOTONS ; SACCHAROSE ; ULTRACENTRIFUGATION</subject><ispartof>Biochemical and biophysical research communications, 2009-07, Vol.385 (2), p.154-159</ispartof><rights>2009 Elsevier Inc.</rights><lds50>peer_reviewed</lds50><woscitedreferencessubscribed>false</woscitedreferencessubscribed><citedby>FETCH-LOGICAL-c382t-a1be4078561de86c21380f25330fc8e0b42383305c30183dc7eb72a06830b9003</citedby><cites>FETCH-LOGICAL-c382t-a1be4078561de86c21380f25330fc8e0b42383305c30183dc7eb72a06830b9003</cites></display><links><openurl>$$Topenurl_article</openurl><openurlfulltext>$$Topenurlfull_article</openurlfulltext><thumbnail>$$Tsyndetics_thumb_exl</thumbnail><linktohtml>$$Uhttps://dx.doi.org/10.1016/j.bbrc.2009.05.028$$EHTML$$P50$$Gelsevier$$H</linktohtml><link.rule.ids>230,314,776,780,881,3536,27903,27904,45974</link.rule.ids><backlink>$$Uhttps://www.ncbi.nlm.nih.gov/pubmed/19445898$$D View this record in MEDLINE/PubMed$$Hfree_for_read</backlink><backlink>$$Uhttps://www.osti.gov/biblio/22199742$$D View this record in Osti.gov$$Hfree_for_read</backlink></links><search><creatorcontrib>Yi, Jae-Sung</creatorcontrib><creatorcontrib>Choo, Hyo-Jung</creatorcontrib><creatorcontrib>Cho, Bong-Rae</creatorcontrib><creatorcontrib>Kim, Hwan-Myung</creatorcontrib><creatorcontrib>Kim, Yong-Nyun</creatorcontrib><creatorcontrib>Ham, Young-Mi</creatorcontrib><creatorcontrib>Ko, Young-Gyu</creatorcontrib><title>Ginsenoside Rh2 induces ligand-independent Fas activation via lipid raft disruption</title><title>Biochemical and biophysical research communications</title><addtitle>Biochem Biophys Res Commun</addtitle><description>Lipid rafts are plasma membrane platforms mediating signal transduction pathways for cellular proliferation, differentiation and apoptosis. Here, we show that membrane fluidity was increased in HeLa cells following treatment with ginsenoside Rh2 (Rh2), as determined by cell staining with carboxy-laurdan (C-laurdan), a two-photon dye designed for measuring membrane hydrophobicity. In the presence of Rh2, caveolin-1 appeared in non-raft fractions after sucrose gradient ultracentrifugation. In addition, caveolin-1 and GM1, lipid raft landmarkers, were internalized within cells after exposure to Rh2, indicating that Rh2 might disrupt lipid rafts. Since cholesterol overloading, which fortifies lipid rafts, prevented an increase in Rh2-induced membrane fluidity, caveolin-1 internalization and apoptosis, lipid rafts appear to be essential for Rh2-induced apoptosis. Moreover, Rh2-induced Fas oligomerization was abolished following cholesterol overloading, and Rh2-induced apoptosis was inhibited following treatment with siRNA for Fas. This result suggests that Rh2 is a novel lipid raft disruptor leading to Fas oligomerization and apoptosis.</description><subject>60 APPLIED LIFE SCIENCES</subject><subject>Antineoplastic Agents - pharmacology</subject><subject>APOPTOSIS</subject><subject>Caveolin 1 - metabolism</subject><subject>CELL PROLIFERATION</subject><subject>CHOLESTEROL</subject><subject>Cholesterol - metabolism</subject><subject>Fas activation</subject><subject>fas Receptor - metabolism</subject><subject>Ginsenoside Rh2</subject><subject>Ginsenosides - pharmacology</subject><subject>HELA CELLS</subject><subject>Humans</subject><subject>LIGANDS</subject><subject>Lipid rafts</subject><subject>LIPIDS</subject><subject>Membrane Microdomains - drug effects</subject><subject>Membrane Microdomains - metabolism</subject><subject>PHOTONS</subject><subject>SACCHAROSE</subject><subject>ULTRACENTRIFUGATION</subject><issn>0006-291X</issn><issn>1090-2104</issn><fulltext>true</fulltext><rsrctype>article</rsrctype><creationdate>2009</creationdate><recordtype>article</recordtype><sourceid>EIF</sourceid><recordid>eNp9kE1r3DAQhkVoaTab_oEciqGQm52R5A8JcikhXxAI9ANyE7I0brTsyo4kL_TfR2YXestlhmHeeRgeQi4oVBRoe7Wp-j6YigHICpoKmDghKwoSSkah_kRWANCWTNKXU3IW4waA0rqVX8gplXXdCClW5Ne98xH9GJ3F4ucrK5y3s8FYbN1f7W2ZR5wwF5-KOx0LbZLb6-RGX-ydzqnJ2SLoIRXWxTBPy-acfB70NuLXY1-TP3e3v28eyqfn-8ebH0-l4YKlUtMea-hE01KLojWMcgEDaziHwQiEvmZc5KExHKjg1nTYd0xDKzj0EoCvyfcDd4zJqWhcQvNqRu_RJMUYlbLLiDW5PKSmML7NGJPauWhwu9UexzmqtuNcds2CY4egCWOMAQc1BbfT4Z-ioBbhaqMW4WoRrqBRWXg--nakz_0O7f-To-EcuD4EMJvYOwzLo-gNWheWP-3oPuK_Aw4tkDg</recordid><startdate>20090724</startdate><enddate>20090724</enddate><creator>Yi, Jae-Sung</creator><creator>Choo, Hyo-Jung</creator><creator>Cho, Bong-Rae</creator><creator>Kim, Hwan-Myung</creator><creator>Kim, Yong-Nyun</creator><creator>Ham, Young-Mi</creator><creator>Ko, Young-Gyu</creator><general>Elsevier Inc</general><scope>CGR</scope><scope>CUY</scope><scope>CVF</scope><scope>ECM</scope><scope>EIF</scope><scope>NPM</scope><scope>AAYXX</scope><scope>CITATION</scope><scope>7X8</scope><scope>OTOTI</scope></search><sort><creationdate>20090724</creationdate><title>Ginsenoside Rh2 induces ligand-independent Fas activation via lipid raft disruption</title><author>Yi, Jae-Sung ; Choo, Hyo-Jung ; Cho, Bong-Rae ; Kim, Hwan-Myung ; Kim, Yong-Nyun ; Ham, Young-Mi ; Ko, Young-Gyu</author></sort><facets><frbrtype>5</frbrtype><frbrgroupid>cdi_FETCH-LOGICAL-c382t-a1be4078561de86c21380f25330fc8e0b42383305c30183dc7eb72a06830b9003</frbrgroupid><rsrctype>articles</rsrctype><prefilter>articles</prefilter><language>eng</language><creationdate>2009</creationdate><topic>60 APPLIED LIFE SCIENCES</topic><topic>Antineoplastic Agents - pharmacology</topic><topic>APOPTOSIS</topic><topic>Caveolin 1 - metabolism</topic><topic>CELL PROLIFERATION</topic><topic>CHOLESTEROL</topic><topic>Cholesterol - metabolism</topic><topic>Fas activation</topic><topic>fas Receptor - metabolism</topic><topic>Ginsenoside Rh2</topic><topic>Ginsenosides - pharmacology</topic><topic>HELA CELLS</topic><topic>Humans</topic><topic>LIGANDS</topic><topic>Lipid rafts</topic><topic>LIPIDS</topic><topic>Membrane Microdomains - drug effects</topic><topic>Membrane Microdomains - metabolism</topic><topic>PHOTONS</topic><topic>SACCHAROSE</topic><topic>ULTRACENTRIFUGATION</topic><toplevel>peer_reviewed</toplevel><toplevel>online_resources</toplevel><creatorcontrib>Yi, Jae-Sung</creatorcontrib><creatorcontrib>Choo, Hyo-Jung</creatorcontrib><creatorcontrib>Cho, Bong-Rae</creatorcontrib><creatorcontrib>Kim, Hwan-Myung</creatorcontrib><creatorcontrib>Kim, Yong-Nyun</creatorcontrib><creatorcontrib>Ham, Young-Mi</creatorcontrib><creatorcontrib>Ko, Young-Gyu</creatorcontrib><collection>Medline</collection><collection>MEDLINE</collection><collection>MEDLINE (Ovid)</collection><collection>MEDLINE</collection><collection>MEDLINE</collection><collection>PubMed</collection><collection>CrossRef</collection><collection>MEDLINE - Academic</collection><collection>OSTI.GOV</collection><jtitle>Biochemical and biophysical research communications</jtitle></facets><delivery><delcategory>Remote Search Resource</delcategory><fulltext>fulltext</fulltext></delivery><addata><au>Yi, Jae-Sung</au><au>Choo, Hyo-Jung</au><au>Cho, Bong-Rae</au><au>Kim, Hwan-Myung</au><au>Kim, Yong-Nyun</au><au>Ham, Young-Mi</au><au>Ko, Young-Gyu</au><format>journal</format><genre>article</genre><ristype>JOUR</ristype><atitle>Ginsenoside Rh2 induces ligand-independent Fas activation via lipid raft disruption</atitle><jtitle>Biochemical and biophysical research communications</jtitle><addtitle>Biochem Biophys Res Commun</addtitle><date>2009-07-24</date><risdate>2009</risdate><volume>385</volume><issue>2</issue><spage>154</spage><epage>159</epage><pages>154-159</pages><issn>0006-291X</issn><eissn>1090-2104</eissn><abstract>Lipid rafts are plasma membrane platforms mediating signal transduction pathways for cellular proliferation, differentiation and apoptosis. Here, we show that membrane fluidity was increased in HeLa cells following treatment with ginsenoside Rh2 (Rh2), as determined by cell staining with carboxy-laurdan (C-laurdan), a two-photon dye designed for measuring membrane hydrophobicity. In the presence of Rh2, caveolin-1 appeared in non-raft fractions after sucrose gradient ultracentrifugation. In addition, caveolin-1 and GM1, lipid raft landmarkers, were internalized within cells after exposure to Rh2, indicating that Rh2 might disrupt lipid rafts. Since cholesterol overloading, which fortifies lipid rafts, prevented an increase in Rh2-induced membrane fluidity, caveolin-1 internalization and apoptosis, lipid rafts appear to be essential for Rh2-induced apoptosis. Moreover, Rh2-induced Fas oligomerization was abolished following cholesterol overloading, and Rh2-induced apoptosis was inhibited following treatment with siRNA for Fas. This result suggests that Rh2 is a novel lipid raft disruptor leading to Fas oligomerization and apoptosis.</abstract><cop>United States</cop><pub>Elsevier Inc</pub><pmid>19445898</pmid><doi>10.1016/j.bbrc.2009.05.028</doi><tpages>6</tpages></addata></record> |
fulltext | fulltext |
identifier | ISSN: 0006-291X |
ispartof | Biochemical and biophysical research communications, 2009-07, Vol.385 (2), p.154-159 |
issn | 0006-291X 1090-2104 |
language | eng |
recordid | cdi_osti_scitechconnect_22199742 |
source | MEDLINE; Elsevier ScienceDirect Journals |
subjects | 60 APPLIED LIFE SCIENCES Antineoplastic Agents - pharmacology APOPTOSIS Caveolin 1 - metabolism CELL PROLIFERATION CHOLESTEROL Cholesterol - metabolism Fas activation fas Receptor - metabolism Ginsenoside Rh2 Ginsenosides - pharmacology HELA CELLS Humans LIGANDS Lipid rafts LIPIDS Membrane Microdomains - drug effects Membrane Microdomains - metabolism PHOTONS SACCHAROSE ULTRACENTRIFUGATION |
title | Ginsenoside Rh2 induces ligand-independent Fas activation via lipid raft disruption |
url | https://sfx.bib-bvb.de/sfx_tum?ctx_ver=Z39.88-2004&ctx_enc=info:ofi/enc:UTF-8&ctx_tim=2025-01-22T09%3A56%3A13IST&url_ver=Z39.88-2004&url_ctx_fmt=infofi/fmt:kev:mtx:ctx&rfr_id=info:sid/primo.exlibrisgroup.com:primo3-Article-proquest_osti_&rft_val_fmt=info:ofi/fmt:kev:mtx:journal&rft.genre=article&rft.atitle=Ginsenoside%20Rh2%20induces%20ligand-independent%20Fas%20activation%20via%20lipid%20raft%20disruption&rft.jtitle=Biochemical%20and%20biophysical%20research%20communications&rft.au=Yi,%20Jae-Sung&rft.date=2009-07-24&rft.volume=385&rft.issue=2&rft.spage=154&rft.epage=159&rft.pages=154-159&rft.issn=0006-291X&rft.eissn=1090-2104&rft_id=info:doi/10.1016/j.bbrc.2009.05.028&rft_dat=%3Cproquest_osti_%3E67339750%3C/proquest_osti_%3E%3Curl%3E%3C/url%3E&disable_directlink=true&sfx.directlink=off&sfx.report_link=0&rft_id=info:oai/&rft_pqid=67339750&rft_id=info:pmid/19445898&rft_els_id=S0006291X09009358&rfr_iscdi=true |